women's health

UCSF Team Identifies Druggable Genes Related to Preterm Birth
Premium

Researchers have flagged 99 genes related to muscle contractility related to spontaneous preterm birth, along with nine potentially therapeutic drugs that target them.

Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split

Aspira Women's Health has been evaluating Dana-Farber's microRNA technology for ovarian cancer detection since early 2021.

women's health

UCSF Team Identifies Druggable Genes Related to Preterm Birth
Premium

Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split

Immatics Prices $150M Stock Offering

Arrivo BioVentures to Explore Biomarkers in Phase I Trial of Drug Candidate for Depression in Women

FDA Approves Genentech's Itovebi Combo for PIK3CA-Mutated Advanced Breast Cancer Patients

In Brief This Week: ADLM, Verismo, Gemma, Denovo, Flatiron Health, Foresight, Naveris

Foundation Medicine Test Approved by FDA as CDx for Itovebi in Breast Cancer Patients

Burning Rock, Dizal Get Chinese Approval for Lung Cancer CDx

women's health

UCSF Team Identifies Druggable Genes Related to Preterm Birth Premium

Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split

Immatics Prices $150M Stock Offering

Arrivo BioVentures to Explore Biomarkers in Phase I Trial of Drug Candidate for Depression in Women

FDA Approves Genentech's Itovebi Combo for PIK3CA-Mutated Advanced Breast Cancer Patients

In Brief This Week: ADLM, Verismo, Gemma, Denovo, Flatiron Health, Foresight, Naveris

Foundation Medicine Test Approved by FDA as CDx for Itovebi in Breast Cancer Patients

Burning Rock, Dizal Get Chinese Approval for Lung Cancer CDx

UCSF Team Identifies Druggable Genes Related to Preterm Birth
Premium